Active-ingredient Dossier
Midazolam
Active-ingredient Dossier for Midazolam (benzodiazepine sedative). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: ZYAMIS
- Brand: HYPNOVEL
- Brand: MIDAZOLAM ACCORD
- Brand: MIDAZOLAM VIATRIS
- Brand: Midazolam-Baxter
- Brand: APO-Midazolam
- Therapeutic area: Neurology
- Therapeutic area: Pain Management
- Therapeutic area: Cardiology
What is
Midazolam Midazolam is a benzodiazepine sedative.
Australian brands containing
Midazolam — ZYAMIS — MIDAZOLAM ACCORD — HYPNOVEL — MIDAZOLAM VIATRIS — Midazolam-Baxter
Therapeutic areas
Midazolam is registered in cardiology (7 brands), complementary medicine (2 brands), and neurology (1 brand).
Sponsor landscape
Midazolam is marketed by nine sponsors, including Accord Healthcare, Arrotex Pharmaceuticals, Pharmaco, Medsurge Pharma, and Pfizer.
PBS and regulatory activity
One brand containing midazolam has PBS-listed items, with the latest PBS schedule date of 1 May 2026. Two brands have PBAC outcomes on record, with the latest PBAC outcome recorded on 1 December 2025.